keyword
https://read.qxmd.com/read/38588915/huntington-s-disease-a-clinical-primer-for-acute-and-general-physicians
#1
REVIEW
Thomas H Massey, Duncan J McLauchlan
Huntington's disease (HD) usually manifests in adulthood and is characterised by progressive neurodegeneration in the brain that causes worsening involuntary movements, mental health and cognition over many years. Depression, anxiety and apathy are common. HD is autosomal dominant and affects about 1 in 8,000 people in the UK. There are currently no disease-modifying treatments and so patient care centres on multidisciplinary therapy support and medical treatments to relieve distressing symptoms. Progression of HD is usually slow, and so acute deteriorations often indicate another problem, such as intercurrent infections, constipation, urinary retention, gastro-oesophageal reflux disease or poor dentition...
April 6, 2024: Clinical Medicine: Journal of the Royal College of Physicians of London
https://read.qxmd.com/read/38575328/validity-and-reliability-of-the-persian-version-of-the-gastroesophageal-reflux-disease-health-related-quality-of-life-questionnaire
#2
JOURNAL ARTICLE
Seyed Ali Ebrahimi, Zahra Mostafavian, Elahe Karazhian, Fereshteh Najafi, Rasam Mashoufi, Tooraj Zandbaf, Elham Mokhtari
OBJECTIVE: The Gastroesophageal Reflux Disease Health-Related Quality of Life (GERD-HRQL) is one of the most widely used questionnaires for assessing typical gastro-oesophageal reflux disease (GORD) symptoms. It is simple, concise, and treatment responsive, yet it has not been validated in the Persian language. This study aimed to translate the GERD-HRQL questionnaire into Persian and assess its validity and reliability. DESIGN: In this cross-sectional validation study, a team of gastroenterologists, general surgeons, and professional translators conducted the forward-backward translation...
April 4, 2024: BMJ Open Gastroenterology
https://read.qxmd.com/read/38554127/use-of-5-alpha-reductase-inhibitors-and-risk-of-gastrointestinal-cancers-in-men-with-benign-prostatic-hyperplasia-a-population-based-cohort-study
#3
JOURNAL ARTICLE
Niamh Doherty, Chris Cardwell, Peter Murchie, Christopher Hill, Laurent Azoulay, Blánaid Hicks
Pre-clinical evidence suggests that 5-alpha reductase inhibitors (5ARi's), prescribed in the treatment of benign prostatic hyperplasia, reduce colorectal and gastro-oesophageal cancer incidence via action on the male hormonal pathway. However, few studies to date have investigated this association at the population level. Our study aimed to investigate the risk of colorectal and gastro-oesophageal cancers with the use of 5ARi's. We conducted a retrospective cohort study of new users of 5ARi's and alpha-blockers among patients with benign prostatic hyperplasia in the UK Clinical Practice Research Datalink...
March 30, 2024: International Journal of Cancer. Journal International du Cancer
https://read.qxmd.com/read/38553042/national-institute-for-health-and-care-excellence-nice-guidance-on-monitoring-and-management-of-barrett-s-oesophagus-and-stage-i-oesophageal-adenocarcinoma
#4
JOURNAL ARTICLE
Massimiliano di Pietro, Nigel J Trudgill, Melina Vasileiou, Gaius Longcroft-Wheaton, Alexander W Phillips, James Gossage, Philip V Kaye, Kieran G Foley, Tom Crosby, Sophie Nelson, Helen Griffiths, Muksitur Rahman, Gill Ritchie, Amy Crisp, Stephen Deed, John N Primrose
Barrett's oesophagus is the only known precursor to oesophageal adenocarcinoma, a cancer with very poor prognosis. The main risk factors for Barrett's oesophagus are a history of gastro-oesophageal acid reflux symptoms and obesity. Men, smokers and those with a family history are also at increased risk. Progression from Barrett's oesophagus to cancer occurs via an intermediate stage, known as dysplasia. However, dysplasia and early cancer usually develop without any clinical signs, often in individuals whose symptoms are well controlled by acid suppressant medications; therefore, endoscopic surveillance is recommended to allow for early diagnosis and timely clinical intervention...
March 29, 2024: Gut
https://read.qxmd.com/read/38549723/early-gastro-oesophageal-junction-perforation-repaired-using-through-the-scope-clips-following-nissen-fundoplication
#5
Phelopatir Anthony, Nagy Andrawis
Early gastric and oesophageal perforations are rare following laparoscopic fundoplications, with an incidence of 0.9%. If managed operatively, omentopexy or redo-fundoplication may be employed. Here, we present the case of a septic 21 year old patient who presented with an early gastro-oesophageal perforation 7 days following laparoscopic Nissen fundoplication, which was successfully repaired endoscopically using haemostatic clips. To date, this technique of perforation repair in the setting of fundoplication has yet to be reported...
March 2024: Journal of Surgical Case Reports
https://read.qxmd.com/read/38545797/characteristics-of-adults-with-potential-refractory-chronic-cough-identified-using-an-algorithm-designed-for-administrative-claims-databases-a-descriptive-study
#6
JOURNAL ARTICLE
Sascha van Boemmel-Wegmann, Kenneth W Altman, Ron Herrera, Philippe Vieira Pires, Priscilla F A Pichardo, Pareen Vora
Objective As population-based studies describing the characteristics of patients with refractory chronic cough (RCC) are sparse, the objective of this descriptive study was to identify and describe such patients using an algorithm developed for administrative claims databases and requiring validation in future. Methods We identified adults with chronic cough (N = 782,121) from Optum Clinformatics™ Data Mart as individuals with a 'cough event' (primary cough event; based on ICD codes/relevant prescriptions) and ≥2 cough events in the 56-180 preceding days...
2024: Science Progress
https://read.qxmd.com/read/38538089/retrograde-tubing-as-a-rescue-treatment-for-megaoesophagus-a-case-report
#7
JOURNAL ARTICLE
Chedva S Weiss, Jonathan Abraham Demma, Benjamin Koplewitz, Channa Maayan, Mordechai Slae
Familial dysautonomia (FD) is a genetic disease of the autonomous and sensory nervous systems. Severe gastro-oesophageal reflux is common and one of the major complications. Some patients with FD develop megaoesophagus. Oesophageal malfunction, accompanied by oesophageal food and secretion retention, results in recurrent aspiration and other severe respiratory complications. Through a traditional case report, we wish to show how reverse tubing of the oesophagus can lead to significant symptomatic improvement in these patients...
March 27, 2024: BMJ Open Gastroenterology
https://read.qxmd.com/read/38531547/nocturnal-gastro-oesophageal-reflux-and-respiratory-symptoms-are-increased-in-sleep-apnoea-comparison-with-the-general-population
#8
JOURNAL ARTICLE
Össur Ingi Emilsson, Thor Aspelund, Christer Janson, Bryndis Benediktsdottir, Sigurdur Juliusson, Greg Maislin, Allan I Pack, Brendan T Keenan, Thorarinn Gislason
AIM: To assess respiratory symptoms and nocturnal gastro-oesophageal reflux (nGER) among untreated obstructive sleep apnoea (OSA) patients, compared with the general population. Also, if nGER associates differently with respiratory symptoms among OSA patients. METHODS: 2 study cohorts were included: 822 newly diagnosed subjects with moderate-severe OSA and 738 Icelandic general population study participants. All participants answered the same questionnaires. Those reporting nGER symptoms at least once per week were defined as 'with nGER'; those without nGER symptoms and without nGER medication were defined as 'no nGER'; and other participants were defined as having 'possible nGER'...
March 25, 2024: BMJ Open Respiratory Research
https://read.qxmd.com/read/38530066/utility-of-mean-nocturnal-baseline-impedance-and-post-reflux-swallow-induced-peristaltic-wave-index-in-clinical-ph-impedance-reflux-study
#9
JOURNAL ARTICLE
Bianca Angelica, Marcus Tippett, Amanda Lim, Stephanie Wong, Paul Kuo
BACKGROUND AND AIMS: Analysis of mean nocturnal baseline impedance (MNBI) and post-reflux swallow-induced peristaltic wave index (PSPWi) have been proposed to increase the diagnostic yield of pH-impedance studies in reflux disease. However, routine use of these indices in clinical studies is yet to be established, particularly with PSPWi, which requires laborious manual analysis. Our study aimed to assess the utility of MNBI and PSPWi and their potential for future incorporation into clinical practice...
March 26, 2024: Internal Medicine Journal
https://read.qxmd.com/read/38519048/long-term-risk-factors-for-developing-barrett-s-oesophagus-in-patients-with-gastro-oesophageal-reflux-disease-a-longitudinal-cohort-study
#10
JOURNAL ARTICLE
Christopher J Byrne, Paul Brennan, James Carberry, James Cotton, John F Dillon
BACKGROUND AND AIMS: Several characteristics are known to affect the risk of Barrett's oesophagus (BO) in the general population, with symptomatic gastro-oesophageal reflux disease (GORD) being a critical risk factor. In this study, we examined factors that influence BO development in people living with GORD. DESIGN: People living with GORD were recruited from an endoscopy unit with lifestyle, medical and prescribing history collected. Logistic regression analysis was undertaken to assess the effects of multiple parameters on the likelihood of developing BO...
March 22, 2024: BMJ Open Gastroenterology
https://read.qxmd.com/read/38506938/how-i-do-it-laparoscopic-intragastric-submucosal-dissection-lisd-for-gastric-and-gastro-oesophageal-junction-early-lesions
#11
JOURNAL ARTICLE
Maira Farrukh, Barbara Braden, Bruno Sgromo
PURPOSE: Laparoscopic intragastric submucosal dissection (LISD) is a novel approach to the resection of gastric lesion that are not amenable to conventional endoscopic approaches. The technique permits favourable access to lesions situated at the cardia and angular notch of the stomach, enables en-bloc resection of large areas of tissue, and can prevent the need of formal gastrectomy or oesophagectomy in selected patients. METHODS: All cases were deemed suitable for LISD by a multidisciplinary team panel following endoscopic assessment (using white light enhancement, chromoendoscopy and magnification endoscopy) that was integrated when needed with EUS, CT scan or PET scan...
March 20, 2024: Langenbeck's Archives of Surgery
https://read.qxmd.com/read/38487395/iatrogenic-eventration-of-the-hemidiaphragm-in-a-post-bariatric-surgery-patient
#12
Leonora E Long, Sam Tharwat Alhayo, Michael Talbot
The aim of this report is to describe the management of an iatrogenic diaphragmatic eventration following surgery to relieve neurogenic symptoms of thoracic outlet syndrome in a patient with a prior history of sleeve gastrectomy. We discuss the case of a 46-year-old woman with a 6-month history of gastro-oesophageal reflux and dyspnoea. Imaging demonstrated a left hemidiaphragm eventration and hiatus hernia. The patient underwent laparoscopic plication of the left hemidiaphragm, repair of the hiatus hernia, and an omega loop gastric bypass, with satisfactory resolution of her symptoms...
March 2024: Journal of Surgical Case Reports
https://read.qxmd.com/read/38485249/comorbidities-associated-with-adult-asthma-a-population-based-matched-cohort-study-in-finland
#13
JOURNAL ARTICLE
Riikka Emilia Lemmetyinen, Sanna Katriina Toppila-Salmi, Anna But, Risto Renkonen, Juha Pekkanen, Jari Haukka, Jussi Karjalainen
BACKGROUND: Asthma is a common chronic disease characterised by variable respiratory symptoms and airflow limitation, affecting roughly 4%-10% of the adult population. Adult asthma is associated with higher all-cause mortality compared to individuals without asthma. In this study, we investigate the comorbidities that may affect the management of asthma. METHODS: Total of 1648 adults with asthma and 3310 individuals without asthma aged 30-93 were matched with age, gender and area of residency, and followed from 1 January 1997 to 31 December 2013...
March 14, 2024: BMJ Open Respiratory Research
https://read.qxmd.com/read/38480051/prognostic-factors-in-clinicopathology-of-oesophagogastric-adenocarcinoma-a-single-centre-longitudinal-study-of-347-cases-over-a-20-year-period
#14
JOURNAL ARTICLE
Qin Huang, Edward Lew, Yuqing Cheng, Kevin Huang, Vikram Deshpande, Shweta Shinagare, Xin Yuan, Jason S Gold, Daniel Wiener, H Christian Weber
Oesophagogastric adenocarcinoma (EGA) includes oesophageal (EA), gastro-oesophageal junctional (GEJA), and gastric (GA) adenocarcinomas. The prognostic values of clinicopathological factors in these tumours remain obscure, especially for GEJA that has been inconsistently classified and staged. We studied the prognosis of EGA patients among the three geographic groups in 347 consecutive patients with a median age of 70 years (range 47-94). All patients were male, and 97.1% were white. Based on tumour epicentre location, EGAs were sub-grouped into EA (over 2 cm above the GEJ; n=3, 18...
February 27, 2024: Pathology
https://read.qxmd.com/read/38479405/the-impact-of-hiatus-hernia-in-hypersensitivity-pneumonitis
#15
JOURNAL ARTICLE
David A Heriot, Carmel J W Stock, Zain-Ul-Abideen Mumtaz, R Gisli Jenkins, Felix Chua, Phillip L Molyneaux, Anand Devaraj, Vasilis Kouranos, Athol U Wells, Elizabetta A Renzoni, Simon P G Padley, Sujal R Desai, Peter M George
No abstract text is available yet for this article.
March 13, 2024: Respirology: Official Journal of the Asian Pacific Society of Respirology
https://read.qxmd.com/read/38452784/efficacy-and-safety-of-one-anastomosis-gastric-bypass-versus-roux-en-y-gastric-bypass-at-5-years-yomega-a-prospective-open-label-non-inferiority-randomised-extension-study
#16
RANDOMIZED CONTROLLED TRIAL
Maud Robert, Tigran Poghosyan, Delphine Maucort-Boulch, Alexandre Filippello, Robert Caiazzo, Adrien Sterkers, Lita Khamphommala, Fabian Reche, Vincent Malherbe, Adriana Torcivia, Toufic Saber, Dominique Delaunay, Carole Langlois-Jacques, Augustin Suffisseau, Sylvie Bin, Emmanuel Disse, François Pattou
BACKGROUND: The multicentre randomised trial YOMEGA (NCT02139813) comparing the one anastomosis gastric bypass (OAGB) with the Roux-en-Y gastric bypass (RYGB) confirmed the non-inferiority of OAGB on weight loss outcomes at 24 months. We aimed to report weight loss, metabolic, and safety outcomes at 5 years. METHODS: YOMEGA is a prospective, open-label, non-inferiority, randomised trial conducted at nine centres in France. Inclusion criteria were BMI of 40 kg/m2 or more, or 35 kg/m2 or more with comorbidities...
April 2024: Lancet Diabetes & Endocrinology
https://read.qxmd.com/read/38445690/applying-lyon-consensus-criteria-in-the-work-up-of-patients-with-extra-oesophageal-symptoms-a-multicentre-retrospective-study
#17
JOURNAL ARTICLE
Francesco Calabrese, Andrea Pasta, Giorgia Bodini, Manuele Furnari, Patrizia Zentilin, Edoardo G Giannini, Daria Maniero, Domenico Della Casa, Giovanni Cataudella, Marzio Frazzoni, Roberto Penagini, Arsiè Elena, Nicola de Bortoli, Pierfrancesco Visaggi, Vincenzo Savarino, Edoardo Savarino, Elisa Marabotto
BACKGROUND: The diagnosis of gastro-oesophageal reflux disease (GERD) based on otolaryngologist's assessment of laryngoscopic findings remains contentious in terms of sensitivity and specificity. AIMS: To evaluate GERD prevalence, applying Lyon 2.0 Consensus criteria, in patients with extra-oesophageal symptoms undergoing laryngoscopic examination and impedance-pH monitoring. METHODS: In this retrospective assessment, we included 470 patients with extra-oesophageal symptoms, either isolated or combined with typical symptoms, who had been referred to six tertiary Italian Gastroenterology Units between January and December 2020...
March 6, 2024: Alimentary Pharmacology & Therapeutics
https://read.qxmd.com/read/38387083/prognostic-value-of-mandard-score-and-nodal-status-for-recurrence-patterns-and-survival-after-multimodal-treatment-of-oesophageal-adenocarcinoma
#18
JOURNAL ARTICLE
Sofie P G Henckens, Dajia Liu, Suzanne S Gisbertz, Marianne C Kalff, Maarten C J Anderegg, David Crull, Freek Daams, Annette D van Dalsen, Jan Willem T Dekker, Marc J van Det, Peter van Duijvendijk, Wietse J Eshuis, Richard P R Groenendijk, Jan Willem Haveman, Richard van Hillegersberg, Misha D P Luyer, Pim B Olthof, Jean-Pierre E N Pierie, Victor D Plat, Camiel Rosman, Jelle P Ruurda, Johanna W van Sandick, Meindert N Sosef, Daan M Voeten, Guy H E J Vijgen, Maarten F Bijlsma, Sybren L Meijer, Maarten C C M Hulshof, Cesar Oyarce, Sjoerd M Lagarde, Hanneke W M van Laarhoven, Mark I van Berge Henegouwen
BACKGROUND: This study evaluated the association of pathological tumour response (tumour regression grade, TRG) and a novel scoring system, combining both TRG and nodal status (TRG-ypN score; TRG1-ypN0, TRG>1-ypN0, TRG1-ypN+ and TRG>1-ypN+), with recurrence patterns and survival after multimodal treatment of oesophageal adenocarcinoma. METHODS: This Dutch nationwide cohort study included patients treated with neoadjuvant chemoradiotherapy followed by oesophagectomy for distal oesophageal or gastro-oesophageal junctional adenocarcinoma between 2007 and 2016...
January 31, 2024: British Journal of Surgery
https://read.qxmd.com/read/38383390/efficacy-and-safety-of-zolbetuximab-plus-chemotherapy-for-advanced-cldn18-2-positive-gastric-or-gastro-oesophageal-adenocarcinoma-a-meta-analysis-of-randomized-clinical-trials
#19
JOURNAL ARTICLE
Francisco Cezar Aquino de Moraes, Eric Pasqualotto, Matheus Pedrotti Chavez, Rafael Oliva Morgado Ferreira, Tiago Biachi De Castria, Rommel Mario Rodríguez Burbano
BACKGROUND: The benefit of adding Zolbetuximab to the treatment in patients with Claudin-18 isoform 2 (CLDN18.2)-positive, human epidermal growth factor receptor 2-negative, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GC/GEJ) is not yet fully elucidated. METHODS: We searched PubMed, Embase and Cochrane databases for randomized controlled trials (RCTs) that investigated Zolbetuximab plus chemotherapy versus chemotherapy alone for GC or GEJ adenocarcinoma...
February 21, 2024: BMC Cancer
https://read.qxmd.com/read/38378669/modification-of-the-paediatric-gastro-oesophageal-reflux-disease-symptom-and-quality-of-life-questionnaire-pgsq-for-children-with-cerebral-palsy-a-preliminary-study
#20
JOURNAL ARTICLE
Sarah Mills, Catherine Tuffrey, Lee Tbaily, Mark Tighe
OBJECTIVE: Gastro-oesophageal reflux disease (GORD) is a common condition affecting children, characterised by the passage of gastric contents into the oesophagus causing pain, vomiting and regurgitation. Children with neurodisability (such as cerebral palsy; CP) are predisposed to more severe GORD due to coexisting gut dysmotility and exclusive/supplementary liquid diet; however, there are no existing tools or outcome measures to assess the severity of GORD in this patient group. For children without CP, the 'Paediatric Gastro-oesophageal Symptom and Quality of Life Questionnaire' (PGSQ) assesses symptoms and response to treatment, but the questions are not suitable for children with significant cognitive impairment...
February 20, 2024: BMJ Paediatrics Open
keyword
keyword
163896
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.